PI
-
Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity
on behalf of the T2B! immunity against SARS-CoV-2 study group, 1 Dec 2023, In: BMC Infectious Diseases. 23, 1, 332.Research output: Contribution to journal › Article › Academic › peer-review
-
Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseases
Wieske, L., Stalman, E. W., van Dam, P. J. K., Kummer, L. Y., Steenhuis, M., van Kempen, Z. L. E., Killestein, J., Volkers, A. G., Tas, S. W., Boekel, L., Wolbink, G., van der Kooi, A., Raaphorst, J., Löwenberg, M., Takkenberg, B., D'Haens, G. R. A. M., Spuls, P. I., Bekkenk, M. W., Musters, A. H., Post, N. F., & 38 others , 1 Jun 2023, In: Annals of the rheumatic diseases. 82, 6, p. 883-885 3 p., ard-2022-223464.Research output: Contribution to journal › Review article › Academic › peer-review
-
Differences in IgG autoantibody Fab glycosylation across autoimmune diseases
T2B Consortium, Jun 2023, In: Journal of allergy and clinical immunology. 151, 6, p. 1646-1654 9 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications